Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 178-182

  Fotiou, Stelios ^a   Aliki, Tserkezoglou ^b   Petros, Zarganis ^a   Ioanna, Stauropoulou ^b   Konstantinos, Velentzas ^a   Vasiliki, Michalaki ^c   George, Creatsas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Agios Savvas Anticancer Institute   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Isolated nodal recurrence; Outcome; Ovarian cancer; Secondary cytoreductive surgery

Indexed keywords

CA 125 ANTIGEN; CYCLOPHOSPHAMIDE; PLATINUM; TAXANE DERIVATIVE; TOPOTECAN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFORMATION; INGUINAL LYMPH NODE; INGUINAL REGION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORBIDITY; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS; PRIORITY JOURNAL; RECURRENT CANCER; RECURRENT DISEASE; REOPERATION; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 67549118434     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.04.025     Document Type: Article

References (31)

1. Yancik R. Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis and mortality. Cancer 71 2 Suppl (1993) S17-S23
2. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 (2002) 1248-1259
3. Ozols R.F., Bundy B.N., Greer B.E., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study. J. Clin. Oncol. 21 (2003) 3194-3200
4. Ozols R.F., Rubin S.C., Thomas G.M., and Robby S.J. Epithelial ovarian cancer. In: Hoskins W.J., Perez C.A., Young R.C., Barakat R., Markman M., and Randall M. (Eds). Principles and Practice of Gynecologic Oncology. 4th ed (2005), Philadelphia, PA, Lippincott-Raver Publishers 895-987
5. Burke T.W., and Morris M. Secondary cytoreductive surgery for ovarian cancer. Obstet. Gynecol. Clin. North Am. 21 (1994) 167-178
6. Vasey P.A. Primary chemotherapy for advanced epithelial ovarian cancer. In: Gershenson D.M., McGuire W.P., Gore M., Quinn M.A., and Thomas G. (Eds). Gynecologic Cancer. Controversies in Management (2004), Elsevier-Churchill Livingstone, Philadelphia PA 429-445
7. Raymond E., Drolet Y., Marpeau L., et al. Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol. 72 (1997) 181-190
8. Eisenkop S.M., Friedman R.L., and Wang H.J. Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study. Cancer 76 (1995) 1606-1614
9. Eisenkop S.M., Friedman R.L., and Spirtos N.M. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 88 (2000) 144-153
10. Tay E.H., Grant P.T., Gebski V., and Hacker N.F. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Obstet. Gynecol. 99 (2002) 1008-1013
11. Tebes S.J., Sayer R.A., Palmer J.M., et al. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol. Oncol. 106 (2007) 482-487
12. Uzan C., Morice P., Rey A., et al. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg. Oncol. 11 (2004) 658-664
13. Santillan A., Karam A.K., Li A.J., et al. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol. Oncol. 104 (2007) 686-690
14. Berek J.S., Hacker N.F., Lagasse L.D., et al. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet. Gynecol. 61 (1983) 189-193
15. Pfisterer J., Harter P., Canzler U., et al. The role of surgery in recurrent ovarian cancer. Int. J. Gynecol. Cancer 15 Suppl.3 (2005) 195-198
16. Janicke F., Holscher M., Kuhn W., et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 70 (1992) 2129-2136
17. Munkarah A., Levenback C., Wolk J.K., et al. Secondary cytoreductive surgery for localized intraabdominal recurrences of epithelial ovarian cancer. Gynecol. Oncol. 81 (2001) 237-241
18. Gadducci A., Iacconi P., Cosio S., Fanucchi A., et al. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol. Oncol. 79 (2000) 344-349
19. Benedetti Panici P., De Vivo A., Bellati F., et al. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Ann. Surg. Oncol. 14 (2007) 1136-1142
20. Burghardt E., Girardi F., Lahousen M., et al. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol. Oncol. 40 (1991) 103-106
21. Morice P., Joulie F., Camatte S., Pater J., and Koski B. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J. Am. Coll. Surg. 197 (2003) 198-2005
22. Landoni F., Pellegrino A., Cornio G., et al. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy. Acta Obstet. Gynecol. Scand 77 (1998) 233-237
23. Kikkawa F., Kawai M., Mizuno K., et al. Recurrence of epithelial ovarian carcinoma after clinical remission. Gynecol. Obstet. Invest. 38 (1994) 65-69
24. di Re F., Baiocchi G., Fontanelli R., et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol. Oncol. 62 (1996) 360-365
25. Fujiwara K., Suzuki S., Yoden E., et al. Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy. Int. J. Gynecol. Cancer 12 (2002) 250-256
26. Blanchard P., Plantade A., Pages C., et al. Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors. Gynecol. Oncol. 104 (2007) 41-45
27. Legge F., Petrillo M., Adamo V., et al. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome. BMC Cancer 8 (2008) 367 10.1186/1471-2407-8-367
28. Bristow R.E., Guintoli R.L., Pannu H.K., et al. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol. Oncol. 99 (2005) 294-300
29. Benedetti Panici P., Perniola G., Angioli R., et al. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery. Int. J. Gynecol. Cancer 17 (2007) 1245-1251
30. Markman M. Decision-making in the management of recurrent epithelial ovarian cancer. In: Gershenson D.M., McGuire W.P., Gore M., Quinn M.A., and Thomas G. (Eds). Gynecologic Cancer. Controversies in management (2004), Elsevire-Churchill Livingstone, Philadelphia PA 447-454
31. Chi D.S., McCaughty K., Diaz J., et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 106 (2006) 1933-1939